T. Rowe Price (NYSE: SEM) holds 165,144 shares of Select Medical (0.1%)

Rhea-AI Filing Summary

Select Medical Holdings Corp ownership disclosure: institutional investor T. Rowe Price Associates, Inc. reports beneficial ownership of 165,144 shares of Common Stock, representing 0.1% of the class as of 03/31/2026. The filer reports sole voting power over 160,606 shares and sole dispositive power over 165,144 shares. The filing is an amendment to a Schedule 13G and includes a signature dated 04/08/2026.

Insights

Institutional Ownership Analyst

T. Rowe Price holds a small passive stake in SEM.

T. Rowe Price reports 165,144 shares (0.1%) with sole dispositive power, consistent with a passive investment disclosed on Schedule 13G/A. The size is below 5% and typically reflects portfolio positioning rather than control intent.

Watch subsequent filings for any increase above 5% that would require a different reporting form.

Securities Compliance Specialist

Filing meets passive-investor disclosure conventions under Section 13.

The amendment affirms limited ownership and includes the filer’s denial of beneficial ownership in boilerplate language. The filing lists voting and dispositive powers clearly, which supports compliance with reporting requirements for institutional holders.

No material corporate governance change is indicated by this disclosure.

Key Figures

Beneficial ownership: 165,144 shares Percent of class: 0.1% Sole voting power: 160,606 shares +1 more

4 metrics

Beneficial ownership 165,144 shares reported as of 03/31/2026

Percent of class 0.1% ownership percentage reported on Schedule 13G/A

Sole voting power 160,606 shares sole power to vote reported in Item 4

Sole dispositive power 165,144 shares sole power to dispose reported in Item 4

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 13 ) SELECT MEDICAL HOLDINGS CORP COMMON STOCK"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned regulatory

"Item 4. | Ownership (a) | Amount beneficially owned: 165144"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"7 | Sole Dispositive Power 165,144.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 13)

SELECT MEDICAL HOLDINGS CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

81619Q105

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 81619Q105

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 160,606.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 165,144.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

165,144.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SELECT MEDICAL HOLDINGS CORP
(b)	Address of issuer's principal executive offices: C/O SELECT MEDICAL CORP, 4714 GETTYSBURG RD, MECHANICSBURG, PA, 17055
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 165144
(b)	Percent of class: 0.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 160606
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 165144
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	04/08/2026

FAQ

What does T. Rowe Price's Schedule 13G/A for SEM disclose?

It discloses that T. Rowe Price Associates, Inc. beneficially owns 165,144 shares of SEM common stock, representing 0.1% of the class as of 03/31/2026. The filing lists voting and dispositive powers and is an amendment.

Does the filing indicate T. Rowe Price controls Select Medical (SEM)?

No. The filing reports sole voting power over 160,606 shares but ownership is 0.1%, which is below thresholds indicating control. The Schedule 13G/A framework signals passive institutional ownership rather than control intent.

What voting and dispositive powers did T. Rowe Price report?

The filer reports sole power to vote 160,606 shares and sole dispositive power over 165,144 shares. No shared voting or dispositive powers are reported in the amendment dated 04/08/2026.

When was the ownership position reported and when was the amendment signed?

The position is reported as of 03/31/2026 and the Schedule 13G/A amendment bears a signature dated 04/08/2026. Those dates anchor the reported share counts and powers in the filing.